244 related articles for article (PubMed ID: 27575724)
1. Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection.
Wu C; Zhao Y; Xiao X; Fan Y; Kloc M; Liu W; Ghobrial RM; Lan P; He X; Li XC
Am J Transplant; 2016 Sep; 16(9):2563-73. PubMed ID: 27575724
[TBL] [Abstract][Full Text] [Related]
2. Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.
Zhao Y; Chen S; Lan P; Wu C; Dou Y; Xiao X; Zhang Z; Minze L; He X; Chen W; Li XC
Am J Transplant; 2018 Mar; 18(3):604-616. PubMed ID: 29044999
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the purinergic pathway prolongs mouse lung allograft survival.
Liu K; Vergani A; Zhao P; Ben Nasr M; Wu X; Iken K; Jiang D; Su X; Fotino C; Fiorina P; Visner GA
Am J Respir Cell Mol Biol; 2014 Aug; 51(2):300-10. PubMed ID: 24661183
[TBL] [Abstract][Full Text] [Related]
4. Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7.
Vergani A; Tezza S; D'Addio F; Fotino C; Liu K; Niewczas M; Bassi R; Molano RD; Kleffel S; Petrelli A; Soleti A; Ammirati E; Frigerio M; Visner G; Grassi F; Ferrero ME; Corradi D; Abdi R; Ricordi C; Sayegh MH; Pileggi A; Fiorina P
Circulation; 2013 Jan; 127(4):463-75. PubMed ID: 23250993
[TBL] [Abstract][Full Text] [Related]
5. Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.
Vergani A; Fotino C; D'Addio F; Tezza S; Podetta M; Gatti F; Chin M; Bassi R; Molano RD; Corradi D; Gatti R; Ferrero ME; Secchi A; Grassi F; Ricordi C; Sayegh MH; Maffi P; Pileggi A; Fiorina P
Diabetes; 2013 May; 62(5):1665-75. PubMed ID: 23315496
[TBL] [Abstract][Full Text] [Related]
6. Oxidized-ATP Attenuates Kidney Allograft Rejection By Inhibiting T-Cell, B-Cell, and Macrophage Activity.
Ding X; Wilson NA; Redfield RR; Panzer SE; Verhoven B; Reese SR; Zhong W; Shi L; Burlingham WJ; Denlinger LC; Djamali A
Kidney360; 2020 Feb; 1(2):106-114. PubMed ID: 35372912
[TBL] [Abstract][Full Text] [Related]
7. Purinergic P2X7 receptor antagonist ameliorates intestinal inflammation in postoperative ileus.
Kimura H; Yamazaki T; Mihara T; Kaji N; Kishi K; Hori M
J Vet Med Sci; 2022 Apr; 84(4):610-617. PubMed ID: 35249909
[TBL] [Abstract][Full Text] [Related]
8. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection.
Young JS; Chen J; Miller ML; Vu V; Tian C; Moon JJ; Alegre ML; Sciammas R; Chong AS
Am J Transplant; 2016 Aug; 16(8):2312-23. PubMed ID: 26928966
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
[TBL] [Abstract][Full Text] [Related]
10. The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells.
Koo TY; Lee JG; Yan JJ; Jang JY; Ju KD; Han M; Oh KH; Ahn C; Yang J
Kidney Int; 2017 Aug; 92(2):415-431. PubMed ID: 28396117
[TBL] [Abstract][Full Text] [Related]
11. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
12. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
13. The impact of P2X7 receptor antagonist, brilliant blue G on graft-versus-host disease in mice after allogeneic hematopoietic stem cell transplantation.
Zhong X; Zhu F; Qiao J; Zhao K; Zhu S; Zeng L; Chen X; Xu K
Cell Immunol; 2016 Dec; 310():71-77. PubMed ID: 27544305
[TBL] [Abstract][Full Text] [Related]
14. Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection.
Li T; Zhang Z; Bartolacci JG; Dwyer GK; Liu Q; Mathews LR; Velayutham M; Roessing AS; Lee YC; Dai H; Shiva S; Oberbarnscheidt MH; Dziki JL; Mullet SJ; Wendell SG; Wilkinson JD; Webber SA; Wood-Trageser M; Watkins SC; Demetris AJ; Hussey GS; Badylak SF; Turnquist HR
J Clin Invest; 2020 Oct; 130(10):5397-5412. PubMed ID: 32644975
[TBL] [Abstract][Full Text] [Related]
15. ATP/P2X7r axis mediates the pathological process of allergic asthma by inducing M2 polarization of alveolar macrophages.
Li R; Shang Y; Hu X; Yu Y; Zhou T; Xiong W; Zou X
Exp Cell Res; 2020 Jan; 386(1):111708. PubMed ID: 31682811
[TBL] [Abstract][Full Text] [Related]
16. M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection.
Zhang H; Li Z; Li W
Front Immunol; 2021; 12():648539. PubMed ID: 33815407
[TBL] [Abstract][Full Text] [Related]
17. Blockage of P2X7R suppresses Th1/Th17-mediated immune responses and corneal allograft rejection via inhibiting NLRP3 inflammasome activation.
Fan X; Zhang J; Dai Y; Shan K; Xu J
Exp Eye Res; 2021 Nov; 212():108792. PubMed ID: 34656546
[TBL] [Abstract][Full Text] [Related]
18. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
van der Touw W; Burrell B; Lal G; Bromberg JS
Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts.
Fabritius C; Ritschl PV; Resch T; Roth M; Ebner S; Günther J; Mellitzer V; Nguyen AV; Pratschke J; Sauter M; Klingel K; Kotsch K
Am J Transplant; 2017 Dec; 17(12):3199-3209. PubMed ID: 28805342
[TBL] [Abstract][Full Text] [Related]
20. Low-dose IL-2 prevents murine chronic cardiac allograft rejection: Role for IL-2-induced T regulatory cells and exosomes with PD-L1 and CD73.
Ravichandran R; Itabashi Y; Fleming T; Bansal S; Bowen S; Poulson C; Bharat A; Bremner R; Smith M; Mohanakumar T
Am J Transplant; 2022 Sep; 22(9):2180-2194. PubMed ID: 35603986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
